{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:23:52Z","timestamp":1783466632848,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BASILE20K0"],"award-info":[{"award-number":["BASILE20K0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BASILE20K0"],"award-info":[{"award-number":["BASILE20K0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BASILE20K0"],"award-info":[{"award-number":["BASILE20K0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["AHRQ R03HS026970"],"award-info":[{"award-number":["AHRQ R03HS026970"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int.J. Behav. Med."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12529-025-10382-x","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:23:05Z","timestamp":1751458985000},"page":"367-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Personal-Level Social Networks on Treatment Adherence, Depression, Anxiety, and Perceived Stigma Among Adults with Cystic Fibrosis: An Egocentric Network Analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Haosen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Papia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Yeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Huenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Pullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"3","key":"10382_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jcf.2023.02.009","volume":"22","author":"EA Cromwell","year":"2023","unstructured":"Cromwell EA, et al. Cystic fibrosis prevalence in the United States and participation in the Cystic Fibrosis Foundation Patient Registry in 2020. J Cyst Fibros. 2023;22(3):436\u201342.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10382_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jcf.2018.05.004","volume":"18","author":"JP Clancy","year":"2019","unstructured":"Clancy JP, et al. CFTR modulator theratyping: current status, gaps and future directions. J Cyst Fibros. 2019;18(1):22\u201334.","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10382_CR3","volume":"13","author":"A Zaher","year":"2021","unstructured":"Zaher A, et al. A review of Trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy. Cureus. 2021;13(7): e16144.","journal-title":"Cureus"},{"issue":"4","key":"10382_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4187\/respcare.09540522","volume":"54","author":"PA Flume","year":"2012","unstructured":"Flume PA, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2012;54(4):522.","journal-title":"Respir Care"},{"issue":"5","key":"10382_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1136\/thorax.57.5.459","volume":"57","author":"LJ Kettler","year":"2002","unstructured":"Kettler LJ, et al. Determinants of adherence in adults with cystic fibrosis. Thorax. 2002;57(5):459.","journal-title":"Thorax"},{"key":"10382_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-3-030-42382-7_21","volume-title":"Cystic fibrosis: a multi-organ system approach","author":"KL Behrhorst","year":"2020","unstructured":"Behrhorst KL, Everhart RS, Schechter MS. Mental health in cystic fibrosis. In: Davis SD, Rosenfeld M, Chmiel J, editors. Cystic fibrosis: a multi-organ system approach. Cham: Springer International Publishing; 2020. p. 429\u201347."},{"issue":"2","key":"10382_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jcf.2019.08.009","volume":"19","author":"L Dhingra","year":"2020","unstructured":"Dhingra L, et al. Addressing the burden of illness in adults with cystic fibrosis with screening and triage: an early intervention model of palliative care. J Cyst Fibros. 2020;19(2):262\u201370.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10382_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1569-1993(03)00020-1","volume":"2","author":"PE Pfeffer","year":"2003","unstructured":"Pfeffer PE, Pfeffer JM, Hodson ME. The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults. J Cyst Fibros. 2003;2(2):61\u20138.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10382_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jcf.2014.04.005","volume":"13","author":"KN Oliver","year":"2014","unstructured":"Oliver KN, et al. Stigma and optimism in adolescents and young adults with cystic fibrosis. J Cyst Fibros. 2014;13(6):737\u201344.","journal-title":"J Cyst Fibros"},{"key":"10382_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2466-14-76","volume":"14","author":"S Pakhale","year":"2014","unstructured":"Pakhale S, et al. Assessment of stigma in patients with cystic fibrosis. BMC Pulm Med. 2014;14:76.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10382_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S2213-2600(22)00434-9","volume":"11","author":"N Mayer-Hamblett","year":"2023","unstructured":"Mayer-Hamblett N, et al. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials. Lancet Respir Med. 2023;11(4):329\u201340.","journal-title":"Lancet Respir Med"},{"key":"10382_CR12","doi-asserted-by":"publisher","first-page":"204062232412644","DOI":"10.1177\/20406223241264477","volume":"15","author":"M Basile","year":"2024","unstructured":"Basile M, et al. The impact of elexacaftor\/tezacaftor\/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study. Therapeutic Advances in Chronic Disease. 2024;15:20406223241264476.","journal-title":"Therapeutic Advances in Chronic Disease"},{"issue":"4","key":"10382_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jcf.2014.12.015","volume":"14","author":"J Abbott","year":"2015","unstructured":"Abbott J, et al. Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery. J Cyst Fibros. 2015;14(4):533\u20139.","journal-title":"J Cyst Fibros"},{"key":"10382_CR14","doi-asserted-by":"publisher","unstructured":"Baroud E, Chaudhary N, Georgiopoulos\u00a0AM.\u00a0Management of neuropsychiatric symptoms in adults treated with elexacaftor\/tezacaftor\/ivacaftor. Pediatr Pulmonol. 2023;58(7):1920\u20131930. https:\/\/doi.org\/10.1002\/ppul.26412.","DOI":"10.1002\/ppul.26412"},{"issue":"2","key":"10382_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jcf.2021.10.002","volume":"21","author":"S Heo","year":"2022","unstructured":"Heo S, et al. Mental status changes during elexacaftor\/tezacaftor \/ ivacaftor therapy. J Cyst Fibros. 2022;21(2):339\u201343.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10382_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jcf.2022.05.001","volume":"21","author":"G Spoletini","year":"2022","unstructured":"Spoletini G, et al. Dose adjustments of elexacaftor\/tezacaftor\/ivacaftor in response to mental health side effects in adults with cystic fibrosis. J Cyst Fibros. 2022;21(6):1061\u20135.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10382_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jcf.2019.01.013","volume":"18","author":"KD Flewelling","year":"2019","unstructured":"Flewelling KD, et al. Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis. J Cyst Fibros. 2019;18(4):572\u20136.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10382_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ppul.21164","volume":"45","author":"KK Marciel","year":"2010","unstructured":"Marciel KK, et al. Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatr Pulmonol. 2010;45(2):157\u201364.","journal-title":"Pediatr Pulmonol"},{"key":"10382_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.socscimed.2013.12.033","volume":"125","author":"BL Perry","year":"2015","unstructured":"Perry BL, Pescosolido BA. Social network activation: the role of health discussion partners in recovery from mental illness. Soc Sci Med. 2015;125:116\u201328.","journal-title":"Soc Sci Med"},{"issue":"4","key":"10382_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.socnet.2010.06.005","volume":"32","author":"BL Perry","year":"2010","unstructured":"Perry BL, Pescosolido BA. Functional specificity in discussion networks: the influence of general and problem-specific networks on health outcomes. Social Networks. 2010;32(4):345\u201357.","journal-title":"Social Networks"},{"key":"10382_CR21","doi-asserted-by":"crossref","unstructured":"Perry BL, Pescosolido BA, Borgatti SP. Egocentric network analysis: foundations, methods, and models. Cambridge University Press; 2018.","DOI":"10.1017\/9781316443255"},{"issue":"5","key":"10382_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/thoraxjnl-2017-210899","volume":"73","author":"S-O Kim","year":"2018","unstructured":"Kim S-O, et al. Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries. Thorax. 2018;73(5):446.","journal-title":"Thorax"},{"issue":"3","key":"10382_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1378\/chest.12-1404","volume":"144","author":"EJ Dill","year":"2013","unstructured":"Dill EJ, et al. Longitudinal trends in health-related quality of life in adults with cystic fibrosis. Chest. 2013;144(3):981\u20139.","journal-title":"Chest"},{"issue":"1","key":"10382_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1378\/chest.13-1926","volume":"146","author":"AL Quittner","year":"2014","unstructured":"Quittner AL, et al. Pulmonary medication adherence and health-care use in cystic fibrosis. Chest. 2014;146(1):142\u201351.","journal-title":"Chest"},{"issue":"9","key":"10382_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10382_CR26","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"1","key":"10382_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0378-8733(99)00017-9","volume":"22","author":"DD Brewer","year":"2000","unstructured":"Brewer DD. Forgetting in the recall-based elicitation of personal and social networks. Social Networks. 2000;22(1):29\u201343.","journal-title":"Social Networks"},{"issue":"2","key":"10382_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1378\/chest.14-1997","volume":"148","author":"JE Pittman","year":"2015","unstructured":"Pittman JE, Ferkol TW. The evolution of cystic fibrosis care. Chest. 2015;148(2):533\u201342.","journal-title":"Chest"},{"issue":"173","key":"10382_CR29","volume":"33","author":"CME Hansen","year":"2024","unstructured":"Hansen CME, et al. Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review. 2024;33(173): 240060.","journal-title":"Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review"},{"issue":"S1","key":"10382_CR30","first-page":"S64","volume":"66","author":"NP Maric","year":"2023","unstructured":"Maric NP, Mihic L. Patient health questionnaire in the general population sample - establishing the cut-off score for detecting major depression. Eur Psychiatry. 2023;66(S1):S64\u20135.","journal-title":"Eur Psychiatry"},{"issue":"5","key":"10382_CR31","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.25183","volume":"18","author":"R Ershad Sarabi","year":"2016","unstructured":"Ershad Sarabi R, et al. The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iran Red Crescent Med J. 2016;18(5): e25183.","journal-title":"Iran Red Crescent Med J"},{"key":"10382_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fpubh.2019.00011","volume":"7","author":"MM Islam","year":"2019","unstructured":"Islam MM. Social determinants of health and related inequalities: confusion and implications. Front Public Health. 2019;7:11.","journal-title":"Front Public Health"},{"issue":"2","key":"10382_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1037\/0033-2909.98.2.310","volume":"98","author":"S Cohen","year":"1985","unstructured":"Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull. 1985;98(2):310\u201357.","journal-title":"Psychol Bull"},{"issue":"1","key":"10382_CR34","doi-asserted-by":"publisher","first-page":"2062820","DOI":"10.1080\/17482631.2022.2062820","volume":"17","author":"M Harrigan","year":"2022","unstructured":"Harrigan M, et al. Living with cystic fibrosis during the COVID-19 pandemic: a social connectedness perspective. Int J Qual Stud Health Well Being. 2022;17(1):2062820.","journal-title":"Int J Qual Stud Health Well Being"},{"key":"10382_CR35","doi-asserted-by":"publisher","first-page":"237437352110140","DOI":"10.1177\/23743735211014049","volume":"8","author":"C George","year":"2021","unstructured":"George C, et al. Partnership Enhancement Program: piloting a communication training program for cystic fibrosis care teams. J Patient Exp. 2021;8:23743735211014050.","journal-title":"J Patient Exp"},{"key":"10382_CR36","unstructured":"Dhingra LDE, Georgiopoulos A, Portenoy RK. Supporting individuals with cystic fibrosis and their families across the lifespan: serious illness discussions. In C. Chase and M.B. Prieur (Chairs), Navigating healthcare and psychosocial transitions through the lifespan., in North American Cystic Fibrosis Conference. Philadelphia, PA. 2022."},{"issue":"6","key":"10382_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jcf.2010.08.016","volume":"9","author":"M George","year":"2010","unstructured":"George M, et al. Perceptions of barriers and facilitators: self-management decisions by older adolescents and adults with CF. Journal of cystic fibrosis\u202f: official journal of the European Cystic Fibrosis Society. 2010;9(6):425\u201332.","journal-title":"Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society"},{"issue":"1","key":"10382_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11096-014-0043-6","volume":"37","author":"A Hogan","year":"2015","unstructured":"Hogan A, et al. Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study. Int J Clin Pharm. 2015;37(1):86\u201393.","journal-title":"Int J Clin Pharm"},{"key":"10382_CR39","doi-asserted-by":"publisher","unstructured":"Basile MPJ, Henthorne K, DeCelie-Germana J, Galvin S, Wang J. The impact of elexacaftor\/tezacaftor\/ivacaftor on cystic fibrosis health-related quality of life and decision making about daily treatment regimens: a mixed methods exploratory study. Ther Adv Chronic Dis. 2024;15. https:\/\/doi.org\/10.1177\/20406223241264477.","DOI":"10.1177\/20406223241264477"},{"issue":"2","key":"10382_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1753465814524471","volume":"8","author":"P Lomas","year":"2014","unstructured":"Lomas P. Enhancing adherence to inhaled therapies in cystic fibrosis. Ther Adv Respir Dis. 2014;8(2):39\u201347.","journal-title":"Ther Adv Respir Dis"},{"issue":"12","key":"10382_CR41","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/thx.51.12.1233","volume":"51","author":"J Abbott","year":"1996","unstructured":"Abbott J, Dodd M, Webb AK. Health perceptions and treatment adherence in adults with cystic fibrosis. Thorax. 1996;51(12):1233\u20138.","journal-title":"Thorax"},{"issue":"2","key":"10382_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MCP.0000000000000244","volume":"22","author":"AL Quittner","year":"2016","unstructured":"Quittner AL, Saez-Flores E, Barton JD. The psychological burden of cystic fibrosis. Curr Opin Pulm Med. 2016;22(2):187\u201391.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10382_CR43","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1186\/s40064-016-2862-5","volume":"5","author":"KB Knudsen","year":"2016","unstructured":"Knudsen KB, et al. Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis. Springerplus. 2016;5(1):1216.","journal-title":"Springerplus"},{"issue":"1","key":"10382_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcf.2020.07.020","volume":"20","author":"MS Schechter","year":"2021","unstructured":"Schechter MS, et al. Decreased survival in cystic fibrosis patients with a positive screen for depression. J Cyst Fibros. 2021;20(1):120\u20136.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10382_CR45","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.jcf.2021.06.007","volume":"21","author":"S Allgood","year":"2022","unstructured":"Allgood S, et al. Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: a mixed methods study. J Cyst Fibros. 2022;21(1):e15\u201322.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10382_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2307\/2676360","volume":"41","author":"BL Fife","year":"2000","unstructured":"Fife BL, Wright ER. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV\/AIDS and cancer. J Health Soc Behav. 2000;41(1):50\u201367.","journal-title":"J Health Soc Behav"}],"container-title":["International Journal of Behavioral Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12529-025-10382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12529-025-10382-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12529-025-10382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:02:59Z","timestamp":1783465379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12529-025-10382-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10382"],"URL":"https:\/\/doi.org\/10.1007\/s12529-025-10382-x","relation":{},"ISSN":["1070-5503","1532-7558"],"issn-type":[{"value":"1070-5503","type":"print"},{"value":"1532-7558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"14 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement Regarding the Welfare of Animals"}},{"value":"External funding:\u2022 Melissa Basile has received additional funding from the Cystic Fibrosis Foundation that is irrelevant to the submitted work.\u2022 Janice Wang reports grants from the Cystic Fibrosis Foundation (CFF) that are, irrelevant to the submitted work.Consultation fess:JW reports consultation fees from the Data Safety Monitoring Board of CFF that are irrelevant to the submitted work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}